| Literature DB >> 17027636 |
Maurice L J Moncany1, Karine Dalet, Pascal R R Courtois.
Abstract
Considering that recombinations produce quasispecies in lentivirus spreading, we identified and localized highly conserved sequences that may play an important role in viral ontology. Comparison of entire genomes, including 237 human, simian and non-primate mammal lentiviruses and 103 negative control viruses, led to identify 28 Conserved Lentiviral Sequences (CLSs). They were located mainly in the structural genes forming hot spots particularly in the gag and pol genes and to a lesser extent in LTRs and regulatory genes. The CLS pattern was the same throughout the different HIV-1 subtypes, except for some HIV-1-O strains. Only CLS 3 and 4 were detected in both negative control HTLV-1 oncornaviruses and D-particle-forming simian viruses, which are not immunodeficiency inducers and display a genetic stability. CLSs divided the virus genomes into domains allowing us to distinguish sequence families leading to the notion of 'species self' besides that of 'lentiviral self'. Most of acutely localized CLSs in HIV-1s (82%) corresponded to wide recombination segments being currently reported.Entities:
Mesh:
Year: 2006 PMID: 17027636 PMCID: PMC7172886 DOI: 10.1016/j.crvi.2006.07.001
Source DB: PubMed Journal: C R Biol ISSN: 1631-0691 Impact factor: 1.583
Characteristics of CLSs detected in lentiviral genomes
| Seq. names | Nucleotidic sequences | Mers | Max. trans. | Viral genomes |
|---|---|---|---|---|
| MMy 1 | tggcgcccgaacagggac | 18 | 3;17% | all HIV-1s, HIV-2s, AGMs, CPZs, mac., sooty, mnd., equ., fel. |
| MMy 3 | taaaacatttagtatgggca | 20 | 3;15% | all HIV-2s, AGMs, mac., CPZs and 152/155 HIV-1s, 9/10 sooty, 1/2 mnd. |
| MMy | catcaagcagctatgcaaat | 20 | 3;15% | all HIV-2s, mac., sooty and 146/155 HIV-1s, 1/9 AGM, 2/3 CPZs |
| MMy 28 | agggctgttggaaatgtgg | 19 | 3;16% | all HIV-2s and 154/155 HIV-1s, 7/8 mac., 8/10 sooty, 1/3 CPZ |
| MMy 31 | catgggtaccagcacacaaagg | 22 | 4;18% | all HIV-2s, AGMs, CPZs, mac., sooty, mnd., equ., Sykes' monkey and 154/155 HIV-1s, 2/3 ov. |
| MMy 32 | tggaaaggggaaggagcagt | 20 | 3–4;15–20% | all HIV-1s, HIV-2s, AGMs, mac., sooty, CPZs, Sykes' monkeys, mnd., cap., ov. |
| CLS 1 | atagaagcagaagttat | 17 | 3;18% | all HIV-1s, HIV-2s, AGMs, CPZs, mac., sooty, mnd. and 1/2 cap., 3/9 fel., 2/3 ov. |
| CLS 2 | tttttaaaagaaaagggg | 18 | 3;17% | all CPZs, mnd., sooty, equ., Sykes' monkey and 153/155 HIV-1s, 15/16 HIV-2s, 8/9 AGMs, 7/8 mac. |
| CLS 3 | tagatacaggagctgatg | 18 | 3;17% | all AGMs, CPZs, Sykes' monkey, bov., equ. and 153/155 HIV-1s, 14/16 HIV-2s, 7/8 mac., 9/10 sooty, 1/2 mnd., 7/9 fel., 2/6 ov./cap. |
| CLS 4 | acaaggaccaaaggaacc | 18 | 3–4;17–22% | all HIV-1s, HIV-2s, mac., sooty, mnd., equ. and 7/9 AGMs, 1/3 CPZ, 1/2 bov., 1/2 cap., 6/9 fel., 3/6 ov./cap./ |
| CLS 5 | catgggtaaaagtagtaga | 19 | 3;16% | all CPZs, ov./cap. and 154/155 HIV-1s, 15/16 HIV-2s, 4/9 AGMs, 3/8 mac., 4/10 sooty, 1/2 mnd., 1/2 cap., 2/3 ov. |
| CLS 6 | aaattttcgggtctattacagagaaggcagagatc | 35 | 6;17% | all HIV-2s, AGMs, CPZs, mac., sooty, mnd. and 152/155 HIV-1s |
| CLS 7 | gctacttccctgattg | 16 | 3;19% | all HIV-1s and 2/3 CPZs |
| CLS 8 | ccacctggattcctga | 16 | 2–3;12–19% | all HIV-1s, CPZs and 1/10 sooty |
| CLS 9 | agtactaaatggagaaaa | 18 | 2–3;11–17% | all CPZs and 152/155 HIV-1s |
| CLS 10 | aaaaataaccacagaaagc | 19 | 4;22% | all CPZs, cap. and 141/155 HIV-1s, 1/16 HIV-2, 1/2 mnd., 1/10 sooty |
| CLS 11 | caggggaaagaatagtaga | 19 | 3;16% | all CPZs, mnd., ov./cap. and 153/155 HIV-1s, 2/3 ov. |
| CLS 12 | acaaaaaacatcagaaagaacc | 22 | 3;14% | 153/155 HIV-1s, 1/3 CPZ, 1/2 mnd. |
| CLS 13 | aataaaacaaattataaacatg | 22 | 4;18% | 143/155 HIV-1s, 1/2 cap. |
| CLS 14 | acaaaagtaagaaaaaagcacagcaagc | 28 | 1–7;4–25% | 125/155 HIV-1s |
| CLS 15 | aaactaaagaattacaaaaacaaattacaaaaatt | 35 | 6;17% | 134/155 HIV-1s, 1/3 CPZ |
| CLS 16 | attttaaaagaaggggag | 18 | 3;17% | all Sykes' monkey, mnd. and 144/155 HIV-1s, 12/16 HIV-2s, 1/3 CPZ, 5/8 mac., 4/10 sooty, 1/9 AGM, 1/9 fel. |
| CLS 17 | tccatatccacaaggacc | 18 | 3;17% | 15/16 HIV-2s, 5/8 mac., 3/10 sooty, 1/9 AGM, 1/2 cap., 1/155 HIV-1 |
| CLS 18 | agtaccaacagggtcaga | 18 | 3;17% | all HIV-2s, AGMs, mac. and 8/10 sooty, 1/2 mnd., 1/9 fel. |
| CLS 19 | agcaccacctagcgggag | 18 | 3;17% | all mac. and 14/16 HIV-2s, 8/10 sooty |
| CLS 20 | agcaacagctgttggacg | 18 | 3;17% | all HIV-2s, mac., sooty and 1/9 fel. |
| CLS 21 | cctcctcctcctccccctccagg | 23 | 3;13% | all mac., sooty and 15/16 HIV-2s |
| CLS 22 | tgaaaaacctcaatgccc | 18 | 3;17% | all AGMs, Sykes' monkey and 1/2 mnd |
Abbreviations: CPZ, chimpanzee; AGM, African green monkey; mac., macaque; sooty, sooty mangabey; mnd, mandrill; bov., bovine; fel., feline; equ., equine; cap., caprine; ov., ovine; ov./cap., ovine/caprine.
Mer-length of the sequences.
Maximum of admitted transitions followed by the percentage of variation they represent.
Ratio of genomes in which the tested sequence was found for each viral family.
Fig. 1CLSs localization and genomic organization of HIV-1 and HIV-2. The numbers represent the relative positions of the detected CLS versus that of the MMy 1® (see Section 2). The reference organization of HIV-1 and HIV-2 genomes was represented using HIVBRUCG and HIV-2CAM2 viruses, respectively. Occn.: CLS occasionally found on less than 10% of the studied genomes; occp.: CLS found at an occasional position.
Fig. 2CLSs localization and genomic organization of AGM and Macaque viruses. The numbers represent the relative positions of the detected CLS versus that of the MMy 1® (see Section 2). The reference organization of AGM and Macaques viral genomes was represented using SIVAGM155 and SIU72748 viruses, respectively. Occp.: CLS found at an occasional position.
Fig. 3CLSs localization and genomic organization of CPZ, D-particle-forming viruses, feline and equine viruses. The numbers represent the relative positions of the detected CLS calculated versus that of the MMy 1®, except for D-particle-forming viruses that lack MMy 1®, whose numbers correspond to the crude positions of the CLSs directly referenced from the genomes (see Section 2). The reference organization of CPZ, D-particle-forming viruses, feline and equine viruses was represented using: AF103818, AF033815, FIVZ1 and AF247394 viruses, respectively. Occp.: CLS found at an occasional position.
Classification of CLSs detection according to primate lentiviral families
| HIV-1 | HIV-2 | AGM | Macaques | Sooty M. | CPZ. | Mandrill | Sykes' monkey | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MMy 1 | ● | PBS – U5 | ● | PBS – U5 | ● | PBS | ● | PBS | ● | PBS | ● | PBS | ● | PBS | ||
| MMy 3 | ● | gag (p17) | ● | gag | ● | gag | ● | gag | ● | gag | ● | gag | ■ | gag | ||
| MMy | ● | gag (p24) | ● | gag | ■ | gag – pol | ● | gag | ● | gag | ■ | gag / | ||||
| MMy 28 | ● | gag (p7) | ● | gag | ■ | gag | ■ | gag | ■ | gag / pol | ||||||
| MMy 31 | ● | pol (p15) | ● | pol | ● | pol | ● | pol | ● | pol | ● | pol / | ● | pol | ● | pol |
| MMy 32 | ● | pol (p31) | ● | pol | ● | pol | ● | pol | ● | pol | ● | vif | ● | pol | ● | vif |
| CLS 1 | ● | pol (p31) / | ● | pol / | ● | pol / | ● | pol | ● | pol / | ● | pol | ● | pol / vif | ||
| CLS 2 | ● | pol (p31) / nef | ● | ■ | nef | ■ | nef | ● | nef | ● | pol / nef | ● | pol / nef | ● | vif | |
| CLS 3 | ● | gag (p6) – | ■ | pol | ● | pol | ■ | pol | ● | pol | ● | pol | ■ | pol | ● | pol |
| pol (p10) | ||||||||||||||||
| CLS 4 | ● | gag (p24) | ● | gag / | ■ | gag | ● | gag | ● | gag | ■ | gag / vpr | ● | gag | ||
| CLS 5 | ● | gag (p24) | ● | gag | ■ | gag | ■ | gag | ■ | gag | ● | gag | ■ | gag | ||
| CLS 6 | ● | pol (p31) | ● | pol | ● | pol | ● | pol | ● | pol | ● | pol / vif | ● | pol | ||
| CLS 7 | ● | nef / | ■ | LTR / nef / | ||||||||||||
| CLS 8 | ● | pol (p51) | ■ | pol | ● | pol | ||||||||||
| CLS 9 | ● | pol (p51) | ● | pol | ||||||||||||
| CLS 10 | ● | ○ | env | ■ | env | ● | pol | ■ | pol | |||||||
| pol (p51) | ||||||||||||||||
| CLS 11 | ● | pol (p31) / | ● | pol | ● | pol | ||||||||||
| CLS 12 | ● | pol (p51) | ■ | pol | ■ | pol | ||||||||||
| CLS 13 | ● | |||||||||||||||
| env (gp120–V4) | ||||||||||||||||
| CLS 14 | ■ | gag (p17) / | ||||||||||||||
| CLS 15 | ■ | pol (p31) | ■ | pol | ||||||||||||
| CLS 16 | ● | pol (p31) | ■ | pol | ■ | pol | ■ | pol | ■ | pol | ■ | pol / | ■ | pol | ● | vif |
| CLS 17 | ○ | vif | ● | env | ■ | rev | ■ | env | ■ | tat – rev – env | ||||||
| CLS 18 | ● | gag / | ● | gag / | ● | gag / | ■ | gag | ■ | gag | ||||||
| CLS 19 | ■ | gag | ● | gag | ■ | gag | ||||||||||
| CLS 20 | ● | env | ● | env | ● | env | ||||||||||
| CLS 21 | ● | vpx | ● | vpx | ● | vpx | ||||||||||
| CLS 22 | ● | env | ■ | gag | ● | tat | ||||||||||
Detection degree of the tested CLS in the genomes: (●) at least 90%; (■) comprised between 10% and 89%; (○) less than 10%.
Gene location of the CLSs: genes separated by ( / ) when CLS was detected on each of the two genes; genes separated by (–) when CLS overlapped the 2 genes; gene indicated in italics when CLS was present at an occasional position.
A gradual detection of CLS 14 was observed when the admitted transitions in this sequence varied from 1 (66%) to 7 (85%).
Classification of CLSs detection according to non-primate mammal lentiviral families
| HIV-1 | HIV-2 | Bovine | Equine | Feline | Caprine | Ovine | Ov./Cap. | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MMy 1 | ● | PBS – U5 | ● | PBS – U5 | ● | PBS – LTR | ● | PBS | ||||||||
| MMy 31 | ● | pol (p15) | ● | pol | ● | pol | ■ | pol | ||||||||
| MMy 32 | ● | pol (p31) | ● | pol | ● | pol | ● | pol | ||||||||
| CLS 1 | ● | pol (p31) / | ● | pol / | ■ | pol / env | ■ | pol | ■ | env | ||||||
| CLS 2 | ● | pol (p31) / nef | ● | ● | gag | |||||||||||
| CLS 3 | ● | gag (p6) – | ○ | pol | ● | pol | ● | pol | ■ | pol | ■ | pol | ||||
| pol (p10) | ||||||||||||||||
| CLS 4 | ● | gag (p24) | ● | gag / | ■ | gag / pol | ● | gag | ■ | gag / | ■ | env | ■ | pol | ||
| CLS 5 | ● | gag (p24) | ● | gag | ■ | pol | ■ | pol | ● | pol | ||||||
| CLS 10 | ● | ○ | env | ● | vif | |||||||||||
| CLS 11 | ● | pol (p31) / | ■ | env | ● | env | ||||||||||
| CLS 13 | ● | ■ | n.a. | |||||||||||||
| env (gp120-V4) | ||||||||||||||||
| CLS 16 | ● | pol (p31) | ■ | pol | ■ | pol | ||||||||||
| CLS 17 | ○ | vif | ● | env | ■ | pol | ||||||||||
| CLS 18 | ● | gag / | ■ | pol | ||||||||||||
| CLS 20 | ● | env | ■ | pol | ||||||||||||
Detection degree of the tested CLS in the genomes: (●) at least 90%; (■) comprised between 10% and 89%; (○) less than 10%.
Gene location of the CLSs: genes separated by ( / ) when CLS was detected on each of the two genes; genes separated by (–) when CLS overlapped the 2 genes; gene indicated in italics when CLS was present at an occasional position.
n.a.: not attributed.
Correlation between recombinogenic segments described in HIV-1s and CLSs
| Reference number | Gene location of reported recombinogenic segments | CLSs detected in corresponding segments |
|---|---|---|
| MMy 1 | ||
| MMy 3, 28, CLS 4, 10, 14 | ||
| MMy 31, 32, CLS 1–3, 8–10, 12, 16 | ||
| CLS 14, 17 | ||
| CLS 11, 13 | ||
| CLS 2, 7 | ||
| CLS 7 |